4.6 Article

MicroRNA-21 mediated cross-talk between cardiomyocytes and fibroblasts in patients with atrial fibrillation

Related references

Note: Only part of the references are listed.
Article Cardiac & Cardiovascular Systems

Atrial Structural Remodeling in Patients With Atrial Fibrillation Is a Diffuse Fibrotic Process: Evidence From High-Density Voltage Mapping and Atrial Biopsy

Takanori Yamaguchi et al.

Summary: Voltage reduction in the left atrium (LA) is a diffuse process associated with fibrosis, and the presence of low-voltage areas (LVAs) reflects the diffuse voltage reduction of the LA.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2022)

Article Medicine, General & Internal

Cryoablation or Drug Therapy for Initial Treatment of Atrial Fibrillation

Jason G. Andrade et al.

Summary: In patients with symptomatic, paroxysmal atrial fibrillation, catheter cryoballoon ablation was associated with a significantly lower rate of atrial fibrillation recurrence compared to antiarrhythmic drug therapy. The ablation group also had better outcomes in terms of atrial tachyarrhythmia occurrence and atrial fibrillation burden.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Cardiac & Cardiovascular Systems

Efficacy of LGE-MRI-guided fibrosis ablation versus conventional catheter ablation of atrial fibrillation: The DECAAF II trial: Study design

Nassir F. Marrouche et al.

Summary: The DECAAF II trial is a prospective, randomized, multicenter trial assessing the safety and efficacy of targeting atrial fibrosis during ablation of persistent AF patients. With 900 patients enrolled, the study aims to define the optimal approach to catheter ablation of persistent AF and identify influencers of ablation lesion formation.

JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY (2021)

Review Cardiac & Cardiovascular Systems

Atrial fibrosis and substrate based characterization in atrial fibrillation: Time to move forwards

Jing X. Quah et al.

Summary: Atrial fibrillation (AF) is a common cardiac arrhythmia with limited therapeutic options due to gaps in understanding the mechanisms sustaining it. Atrial fibrosis plays a central role in AF maintenance and perpetuation, impacting conduction velocity and promoting unstable wavelets. Various imaging techniques can detect fibrosis, and current interventions include drugs, catheter ablation, and potential future use of electro phenotyping for characterization.

JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY (2021)

Article Biochemistry & Molecular Biology

Therapeutic miR-21 Silencing Reduces Cardiac Fibrosis and Modulates Inflammatory Response in Chronic Chagas Disease

Carolina Kymie Vasques Nonaka et al.

Summary: The study found upregulation of miR-21 in chronic Chagas disease patients and mouse heart samples, indicating its important role in regulating cardiac fibrosis. Experimental validation showed that inhibiting miR-21 significantly reduced cardiac fibrosis.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Biochemistry & Molecular Biology

Role of HDACs in cardiac electropathology: Therapeutic implications for atrial fibrillation

Bianca J. J. M. Brundel et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2020)

Article Cardiac & Cardiovascular Systems

Anti-fibrotic effects of curcumin and some of its analogues in the heart

Armita Mahdavi Gorabi et al.

HEART FAILURE REVIEWS (2020)

Review Immunology

Transforming growth factor-beta in tissue fibrosis

Nikolaos G. Frangogiannis

JOURNAL OF EXPERIMENTAL MEDICINE (2020)

Review Cardiac & Cardiovascular Systems

Myofibroblasts and Fibrosis Mitochondrial and Metabolic Control of Cellular Differentiation

Andrew A. Gibb et al.

CIRCULATION RESEARCH (2020)

Article Cardiac & Cardiovascular Systems

HDAC (Histone Deacetylase) Inhibitor Valproic Acid Attenuates Atrial Remodeling and Delays the Onset of Atrial Fibrillation in Mice

Beatrix Scholz et al.

CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY (2019)

Article Cardiac & Cardiovascular Systems

MicroRNA-21 via Dysregulation of WW Domain-Containing Protein 1 Regulate Atrial Fibrosis in Atrial Fibrillation

Hui Tao et al.

HEART LUNG AND CIRCULATION (2018)

Article Cell Biology

miR-21 promotes cardiac fibroblast-to-myofibroblast transformation and myocardial fibrosis by targeting Jagged1

Xue-liang Zhou et al.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2018)

Article Biotechnology & Applied Microbiology

The Transcription Factor ATF4 Promotes Expression of Cell Stress Genes and Cardiomyocyte Death in a Cellular Model of Atrial Fibrillation

Johanna K. Freundt et al.

BIOMED RESEARCH INTERNATIONAL (2018)

Article Cell Biology

Mir-21 Promotes Cardiac Fibrosis After Myocardial Infarction Via Targeting Smad7

Jinxia Yuan et al.

CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)

Review Pharmacology & Pharmacy

Targeting histone deacetylases: A novel therapeutic strategy for atrial fibrillation

Baigalmaa Lkhagva et al.

EUROPEAN JOURNAL OF PHARMACOLOGY (2016)

Article Biochemistry & Molecular Biology

Anti-Fibrotic Effects of Class I HDAC Inhibitor, Mocetinostat Is Associated with IL-6/Stat3 Signaling in Ischemic Heart Failure

Hikmet Nural-Guvener et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)

Article Medicine, General & Internal

Association of Atrial Tissue Fibrosis Identified by Delayed Enhancement MRI and Atrial Fibrillation Catheter Ablation The DECAAF Study

Nassir F. Marrouche et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)

Article Cardiac & Cardiovascular Systems

MicroRNA29 A Mechanistic Contributor and Potential Biomarker in Atrial Fibrillation

Kristin Dawson et al.

CIRCULATION (2013)

Article Cardiac & Cardiovascular Systems

Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060

Bouwe P. Krijthe et al.

EUROPEAN HEART JOURNAL (2013)

Article Cardiac & Cardiovascular Systems

Role for MicroRNA-21 in Atrial Profibrillatory Fibrotic Remodeling Associated With Experimental Postinfarction Heart Failure

Sophie Cardin et al.

CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY (2012)

Review Biochemistry & Molecular Biology

A microRNA component of the hypoxic response

R. Kulshreshtha et al.

CELL DEATH AND DIFFERENTIATION (2008)

Article Cardiac & Cardiovascular Systems

Atrial fibrillation: classification, pathophysiology, mechanisms and drug treatment

V Markides et al.

HEART (2003)

Review Cardiac & Cardiovascular Systems

Electrical, contractile and structural remodeling during atrial fibrillation

M Allessie et al.

CARDIOVASCULAR RESEARCH (2002)